| 发明名称 |
Pharmaceutical formulation |
| 摘要 |
The instant invention provides a pharmaceutical composition comprised of a cholesterol absorption inhibitor and an HMG-CoA reductase inhibitor, one or more anti-oxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose. The composition need not contain ascorbic acid in order to obtain desirable stability.
|
| 申请公布号 |
US7229982(B2) |
申请公布日期 |
2007.06.12 |
| 申请号 |
US20030625004 |
申请日期 |
2003.07.22 |
| 申请人 |
MOORE WILLIAM D;FITZPATRICK SHAUN;SEILER CHRISTIAN;SAKLATVALA ROBERT;PETTS CATHERINE R |
发明人 |
MOORE WILLIAM D.;FITZPATRICK SHAUN;SEILER CHRISTIAN;SAKLATVALA ROBERT;PETTS CATHERINE R. |
| 分类号 |
A61K31/397;A61K9/20;A61K31/22;A61K31/35;A61K31/351;A61K31/365;A61K31/366;A61K31/40;A61K31/404;A61K31/4418;A61K31/46;A61K31/47;A61K45/06;A61K47/08;A61K47/10;A61K47/12;A61K47/14;A61K47/18;A61K47/20;A61K47/22;A61K47/26;A61K47/36;A61K47/38;A61P9/10;A61P43/00 |
主分类号 |
A61K31/397 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
